Resultados de procura - Lukas C. Heukamp
- Mostrando 1 - 20 Resultados de 60
- Go to Next Page
-
1
-
2
TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib por Julia Roeper, Petros Christopoulos, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Albrecht Stenzinger, Michael Thomas, Frank Griesinger
Publicado 2022Artigo -
3
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators por Jörg Ellinger, Patrick J. Bastian, Kim Haan, Lukas C. Heukamp, Reinhard Buettner, Rolf Fimmers, Stefan C. Mueller, Alexander von Ruecker
Publicado 2007Artigo -
4
Identification of three non‐VNTR MUC1‐derived HLA‐A*0201‐restricted T‐cell epitopes that induce protective anti‐tumor immunity in HLA‐A2/Kb‐transgenic mice por Lukas C. Heukamp, Sjoerd H. van der Burg, Jan W. Drijfhout, Cornelis J.M. Melief, Joyce Taylor‐Papadimitriou, Rienk Offringa
Publicado 2001Artigo -
5
Analysis of TET Expression/Activity and 5mC Oxidation during Normal and Malignant Germ Cell Development por Daniel Nettersheim, Lukas C. Heukamp, Florian Fronhoffs, Marc J Grewe, Natalie Haas, Anke Waha, Friedemann Honecker, Andreas Waha, Glen Kristiansen, Hubert Schorle
Publicado 2013Artigo -
6
Hippo Signaling Mediates Proliferation, Invasiveness, and Metastatic Potential of Clear Cell Renal Cell Carcinoma por Ute Schütte, Savita Bisht, Lukas C. Heukamp, Moritz Kebschull, Alexandra Florin, Jens Haarmann, Per Hoffmann, Gerd Bendas, Reinhard Buettner, Peter Brossart, Georg Feldmann
Publicado 2014Artigo -
7
Comparison of Pre-Analytical FFPE Sample Preparation Methods and Their Impact on Massively Parallel Sequencing in Routine Diagnostics por Carina Heydt, Jana Fassunke, Helen Künstlinger, Michaela A. Ihle, Katharina König, Lukas C. Heukamp, Hans‐Ulrich Schildhaus, Margarete Odenthal, Reinhard Büttner, Sabine Merkelbach‐Bruse
Publicado 2014Artigo -
8
Mast cells play a protumorigenic role in primary cutaneous lymphoma por Anja Rabenhorst, Max Schlaak, Lukas C. Heukamp, Anja Förster, Sebastian Theurich, Michael von Bergwelt‐Baildon, Reinhard Büttner, Peter Kurschat, Cornelia Mauch, Axel Roers, Karin Hartmann
Publicado 2012Artigo -
9
A Functional Cancer Genomics Screen Identifies a Druggable Synthetic Lethal Interaction between <i>MSH3</i> and <i>PRKDC</i> por Felix Dietlein, Lisa Thelen, Mladen Jokić, Ron D. Jachimowicz, Laura Ivan, Gero Knittel, Uschi Leeser, Johanna van Oers, Winfried Edelmann, Lukas C. Heukamp, Hans Christian Reinhardt
Publicado 2014Artigo -
10
Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group por Claudia Vollbrecht, Robert A. Werner, Robert Walter, Daniel C. Christoph, Lukas C. Heukamp, Martin Peifer, Burkhard Hirsch, Lina Burbat, Thomas Mairinger, Kurt Werner Schmid, Jeremias Wohlschlaeger, Fabian Mairinger
Publicado 2015Artigo -
11
Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity por Inga Grünewald, Claudia Vollbrecht, J Meinrath, Moritz Meyer, Lukas C. Heukamp, Uta Drebber, Alexander Quaas, Dirk Beutner, Karl‐Bernd Hüttenbrink, Eva Wardelmann, Wolfgang Hartmann, Reinhard Büttner, Margarete Odenthal, Markus Stenner
Publicado 2015Artigo -
12
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants por Johannes M. Heuckmann, Hyatt Balke‐Want, Florian Malchers, Martin Peifer, Martin L. Sos, Mirjam Koker, Lydia Meder, Christine M. Lovly, Lukas C. Heukamp, William Pao, Ralf Küppers, Roman K. Thomas
Publicado 2012Artigo -
13
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas por Annette Künkele, Katleen De Preter, Lukas C. Heukamp, T. Thor, Kristian W. Pajtler, Wolfgang Hartmann, Michel Mittelbronn, Michael A. Grotzer, Hedwig E. Deubzer, Frank Speleman, Alexander Schramm, Angelika Eggert, Johannes H. Schulte
Publicado 2012Artigo -
14
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma por Anton G. Henssen, Theresa Thor, Andrea Odersky, Lukas C. Heukamp, Nicolai El-Hindy, Anneleen Beckers, Frank Speleman, Kristina Althoff, Simon Schäfers, Alexander Schramm, Ulrich Sure, Gudrun Fleischhack, Angelika Eggert, Johannes H. Schulte
Publicado 2013Artigo -
15
Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas por Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp, Korinna Jöhrens, Thomas Kirchner, Simone Reu, Josef Rüschoff, Hans‐Ulrich Schildhaus, Peter Schirmacher, Markus Tiemann, Arne Warth, Wilko Weichert, Rieke Fischer, Jürgen Wolf, Reinhard Buettner
Publicado 2016Artigo -
16
MYCN regulates oncogenic MicroRNAs in neuroblastoma por Johannes H. Schulte, Sebastian Horn, Tobias Otto, Birgit Samans, Lukas C. Heukamp, Ursula‐Christa Eilers, Michael Krause, Kathy Astrahantseff, Ludger Klein‐Hitpaß, Reinhard Buettner, Alexander Schramm, Holger Christiansen, Martin Eilers, Angelika Eggert, Bernd Berwanger
Publicado 2007Artigo -
17
Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens por Judith Müller, Markus Falk, Jatin Talwar, Nicole Neemann, Erika Mariotti, Miriam Bertrand, Tobias Zacherle, Sotirios Lakis, Roopika Menon, Christian Johannes Gloeckner, Markus Tiemann, Lukas C. Heukamp, Roman K. Thomas, Frank Griesinger, Johannes M. Heuckmann
Publicado 2017Artigo -
18
RETRACTED: Cytohesins Are Cytoplasmic ErbB Receptor Activators por Anke Bill, Anton Schmitz, Barbara Albertoni, Jinna Song, Lukas C. Heukamp, David Walrafen, Franziska Thorwirth, Peter J. Verveer, Sebastian Zimmer, Lisa Meffert, Arne Schreiber, Sampurna Chatterjee, Roman K. Thomas, Roland T. Ullrich, Thorsten Lang, Michael Famulok
Publicado 2010Artigo -
19
Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer por Sylvain Delaunay, Francesca Rapino, Lars Tharun, Zhaoli Zhou, Lukas C. Heukamp, Martin Termathe, Kateryna Shostak, Iva Klevernic, Alexandra Florin, Hadrien Desmecht, Christophe Desmet, Laurent Nguyen, Sebastian A. Leidel, Anne E. Willis, Reinhard Büttner, Alain Chariot, Pierre Close
Publicado 2016Artigo -
20
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program por Nikolaj Frost, Petros Christopoulos, Diego Kauffmann‐Guerrero, Jan A. Stratmann, Richard Riedel, Monica Schaefer, Jürgen Alt, S Gütz, Daniel C. Christoph, Eckart Laack, Martin Faehling, Richard Fischer, Klaus Fenchel, Sebastian P. Haen, Lukas C. Heukamp, Christian Schulz, Frank Griesinger
Publicado 2021Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Cancer research
Genetics
Cancer
Gene
Internal medicine
Lung cancer
Oncology
Pathology
Cell biology
Adenocarcinoma
Biochemistry
Immunology
Signal transduction
KRAS
Mutation
Receptor
Apoptosis
Bioinformatics
Cell culture
Computational biology
DNA
Gene expression
Molecular biology
Carcinoma
Cell cycle
Colorectal cancer
Concordance
Crizotinib